149 related articles for article (PubMed ID: 31109334)
21. A Novel Three-LncRNA Signature Predicting Tumor Recurrence in Nonfunctioning Pituitary Adenomas.
Cheng S; Guo J; Wang D; Fang Q; Liu Y; Xie W; Zhang Y; Li C
Front Genet; 2021; 12():754503. PubMed ID: 34745223
[TBL] [Abstract][Full Text] [Related]
22. ZAC1 and SSTR2 are downregulated in non-functioning pituitary adenomas but not in somatotropinomas.
Vieria Neto L; Wildemberg LE; Colli LM; Kasuki L; Marques NV; Moraes AB; Gasparetto EL; Takiya CM; Castro M; Gadelha MR
PLoS One; 2013; 8(10):e77406. PubMed ID: 24098585
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA profile indicates downregulation of the TGFβ pathway in sporadic non-functioning pituitary adenomas.
Butz H; Likó I; Czirják S; Igaz P; Korbonits M; Rácz K; Patócs A
Pituitary; 2011 Jun; 14(2):112-24. PubMed ID: 21063788
[TBL] [Abstract][Full Text] [Related]
24. Accurate assessment of estrogen receptor profiles in non-functioning pituitary adenomas using RT-digital PCR and immunohistochemistry.
Hattori Y; Ishii H; Tahara S; Morita A; Ozawa H
Life Sci; 2020 Nov; 260():118416. PubMed ID: 32926922
[TBL] [Abstract][Full Text] [Related]
25. Digital analysis of hormonal immunostaining in pituitary adenomas classified according to WHO 2017 criteria and correlation with preoperative laboratory findings.
Tamanini JVG; Dal Fabbro M; de Freitas LLL; Vassallo J; de Souza Queiroz L; Rogerio F
Neurosurg Focus; 2020 Jun; 48(6):E12. PubMed ID: 32480373
[TBL] [Abstract][Full Text] [Related]
26. Clinical Characteristics and Postoperative Recovery of Hypopituitarism in Patients with Nonfunctional Pituitary Adenoma.
Zhang R; Wang Z; Gao L; Guo X; Feng C; Deng K; Lian W; Yao Y; Feng M; Bao X; Wang R; Xing B
World Neurosurg; 2019 Jun; 126():e1183-e1189. PubMed ID: 30880207
[TBL] [Abstract][Full Text] [Related]
27. Abnormal response of luteinizing hormone beta subunit to thyrotrophin-releasing hormone in patients with non-functioning pituitary adenoma.
Gil-del-Alamo P; Pettersson KS; Saccomanno K; Spada A; Faglia G; Beck-Peccoz P
Clin Endocrinol (Oxf); 1994 Nov; 41(5):661-6. PubMed ID: 7828356
[TBL] [Abstract][Full Text] [Related]
28. Non-invasive radiomics approach potentially predicts non-functioning pituitary adenomas subtypes before surgery.
Zhang S; Song G; Zang Y; Jia J; Wang C; Li C; Tian J; Dong D; Zhang Y
Eur Radiol; 2018 Sep; 28(9):3692-3701. PubMed ID: 29572634
[TBL] [Abstract][Full Text] [Related]
29. Pituitary apoplexy in non-functioning pituitary adenomas: long term follow up is important because of significant numbers of tumour recurrences.
Pal A; Capatina C; Tenreiro AP; Guardiola PD; Byrne JV; Cudlip S; Karavitaki N; Wass JA
Clin Endocrinol (Oxf); 2011 Oct; 75(4):501-4. PubMed ID: 21521336
[TBL] [Abstract][Full Text] [Related]
30. Expression of Ki-67, PTTG1, FGFR4, and SSTR 2, 3, and 5 in nonfunctioning pituitary adenomas: a high throughput TMA, immunohistochemical study.
Ramírez C; Cheng S; Vargas G; Asa SL; Ezzat S; González B; Cabrera L; Guinto G; Mercado M
J Clin Endocrinol Metab; 2012 May; 97(5):1745-51. PubMed ID: 22419713
[TBL] [Abstract][Full Text] [Related]
31. MRI radiomics for the prediction of recurrence in patients with clinically non-functioning pituitary macroadenomas.
Machado LF; Elias PCL; Moreira AC; Dos Santos AC; Murta Junior LO
Comput Biol Med; 2020 Sep; 124():103966. PubMed ID: 32860977
[TBL] [Abstract][Full Text] [Related]
32. CDKN2A/p16 inactivation is related to pituitary adenoma type and size.
Seemann N; Kuhn D; Wrocklage C; Keyvani K; Hackl W; Buchfelder M; Fahlbusch R; Paulus W
J Pathol; 2001 Apr; 193(4):491-7. PubMed ID: 11276008
[TBL] [Abstract][Full Text] [Related]
33. Audit of selected patients with nonfunctioning pituitary adenomas treated without irradiation - a follow-up study.
Turner HE; Stratton IM; Byrne JV; Adams CB; Wass JA
Clin Endocrinol (Oxf); 1999 Sep; 51(3):281-4. PubMed ID: 10469006
[TBL] [Abstract][Full Text] [Related]
34. Chromosomal and oxidative DNA damage in non-functioning pituitary adenomas.
Bitgen N; Bayram F; Hamurcu Z; Ozturk F; Simsek Y; Baskol G; Kurtsoy A; Donmez-Altuntas H
Endokrynol Pol; 2021; 72(2):97-103. PubMed ID: 33295635
[TBL] [Abstract][Full Text] [Related]
35. KISS1 receptor is preferentially expressed in clinically non-functioning pituitary tumors.
Yaron M; Renner U; Gilad S; Stalla GK; Stern N; Greenman Y
Pituitary; 2015 Jun; 18(3):306-11. PubMed ID: 24817066
[TBL] [Abstract][Full Text] [Related]
36. Magnetic resonance imaging after transsphenoidal surgery of clinically non-functional pituitary macroadenomas and its impact on detecting residual adenoma.
Kremer P; Forsting M; Ranaei G; Wüster C; Hamer J; Sartor K; Kunze S
Acta Neurochir (Wien); 2002 May; 144(5):433-43. PubMed ID: 12111499
[TBL] [Abstract][Full Text] [Related]
37. Expression of CRABP1, GRP, and RERG mRNA in clinically non-functioning and functioning pituitary adenomas.
Chile T; Corrêa-Giannella ML; Fortes MA; Bronstein MD; Cunha-Neto MB; Giannella-Neto D; Giorgi RR
J Endocrinol Invest; 2011 Sep; 34(8):e214-8. PubMed ID: 21270509
[TBL] [Abstract][Full Text] [Related]
38. Natural history of non-functioning pituitary microadenomas: results from the UK non-functioning pituitary adenoma consortium.
Hamblin R; Fountas A; Lithgow K; Loughrey PB; Bonanos E; Shinwari SK; Mitchell K; Shah S; Grixti L; Matheou M; Isand K; McLaren DS; Surya A; Ullah HZ; Klaucane K; Jayasuriya A; Bhatti S; Mavilakandy A; Ahsan M; Mathew S; Hussein Z; Jansz T; Wunna W; MacFarlane J; Ayuk J; Abraham P; Drake WM; Gurnell M; Brooke A; Baldeweg SE; Sam AH; Martin N; Higham C; Reddy N; Levy MJ; Ahluwalia R; Newell-Price J; Vamvakopoulos J; Krishnan A; Lansdown A; Murray RD; Pal A; Bradley K; Mamoojee Y; Purewal T; Panicker J; Freel EM; Hasan F; Kumar M; Jose B; Hunter SJ; Karavitaki N
Eur J Endocrinol; 2023 Jul; 189(1):87-95. PubMed ID: 37345849
[TBL] [Abstract][Full Text] [Related]
39. Association of TGF-β1 and WIF1 Expression with 36 Paired Primary/Recurrent Nonfunctioning Pituitary Adenomas: A High-Throughput Tissue Microarrays Immunohistochemical Study.
Zhu H; Yao X; Wu L; Li C; Bai J; Gao H; Ji H; Zhang Y
World Neurosurg; 2018 Nov; 119():e23-e31. PubMed ID: 29966778
[TBL] [Abstract][Full Text] [Related]
40. Functions and Mechanisms of Tumor Necrosis Factor-α and Noncoding RNAs in Bone-Invasive Pituitary Adenomas.
Zhu H; Guo J; Shen Y; Dong W; Gao H; Miao Y; Li C; Zhang Y
Clin Cancer Res; 2018 Nov; 24(22):5757-5766. PubMed ID: 29980532
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
